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ABSTRACT  This paper compares legislation on clinical research conducted on
patients subject to coercion in the Scandinavian countries and the UK, examines it from a
human rights perspective, and problematizes the Danish legal model as the only one
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employing a total ban on this kind of research. Reference is made to the consequences to
evidence-based psychiatric care improvements and international ethical principle state-
ments generally entitling psychiatric patients to treatment under similar ethical and scien-
tific conditions as patients with other illnesses, given the absolute premise that the patient
does not object to research participation and always retains the right to withdraw.
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1 Introduction
According to Danish law, patients who are subjected to coercive measures may not
participate in ‘experimental treatment’ (Danish: [Forsøgsbehandling]).1 The cur-
rent interpretation of this prohibition has many consequences for Danish psychi-
atric research and may block important initiatives to investigate better means of
treating a significant group of patients. In this paper, we compare Danish legislation
to regulation in other Scandinavian countries and the UK and examine it through
the lens of international human rights. By way of introduction, we describe general
legal principles regarding coercion in psychiatry. Likewise, requirements for con-
sent to research participation are described with reference to different codes of
practice and international soft law instruments. Subsequently, legislation on clini-
cal research conducted in patients subject to coercion in Sweden, Norway and the
UK is described followed by a description of the situation in Denmark. Finally, the
topic is discussed in the light of theory regarding the capacity to consent in psy-
chotic patients and individuals subject to involuntary commitment.
1.1 Coercion in psychiatry – introductory remarks 
Psychiatric coercive measures constitute a serious break with common health law
principles about patient autonomy. They represent one of the most significant
exemptions from the general requirement for obtaining informed consent and for
patient involvement in healthcare decision-making.2,3 However, the necessity for
coercion in some special clinical situations is widely acknowledged. The Oviedo
Convention states that ‘a person who has a mental disorder of a serious nature
may be subjected, without his or her consent, to an intervention aimed at treating
his or her mental disorder only where, without such treatment, serious harm is
1. ACMP. Danish Act on Coercive Measures in Psychiatry, [Bekendtgørelse af lov om anvendelse af 
tvang i psykiatrien], 1160 (2015), Para 23.
2. DHA. The Danish Healthcare Act [Sundhedsloven], 191 (2018).
3. Søren Birkeland and Frederik A Gildberg, ’Mental Health Nursing, Mechanical Restraint Measures 
and Patients' Legal Rights’ (2016) 10 (8) Open Nursing Journal 8. DOI: https://doi.org/10.2174/
1874434601610010008.
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likely to result to his or her health’ (Section 7).4 Similarly, interventions against
‘persons of unsound mind’ may in some situations be consistent with the European
Convention on Human Rights (Article 5).5 According to Danish law, coercion in
terms of involuntary admission to psychiatric hospital, forced treatment, and
physical restraints can be used if certain criteria are met.6 As a point of departure,
however, efforts always must be exercised to obtain the patient’s consent.7
1.2 Consent to research – general principles
Following the Second World War, the Nuremberg Code in 1947 was established as
a set of research ethics principles for human experimentation.89 As a major point,
the code states that ‘voluntary consent […] is absolutely essential […] the person
involved should have legal capacity to give consent; should be so situated as to be
able to exercise free power of choice, without the intervention of any element of
force, fraud, deceit, duress, over-reaching, or other ulterior form of constraint or
coercion […]’(1st Para).10 Furthermore, the code maintains that experiments
should aim at results that cannot be procured in any other way (2nd Para), and they
should be set up in a way that ensures that unnecessary physical and mental suffe-
ring and injuries are avoided (4th Para). Additionally, they may not imply any risk
of death or disabling injury (5th Para). Likewise, it is crucial that human subjects
are free to immediately quit any experiment at any point and medical staff simi-
larly must stop the experiment if they observe that continuation would be dan-
gerous (9th and 10th Paras).
Nonetheless, unethical practices continued beyond WWII. One example of
infamous and unethical research is the U.S. Public Health Service Syphilis Study at
Tuskegee conducted between 1932 and 1972, in which the natural history of syph-
ilis was followed by officials in a cohort of black men without offering medical
treatment, even once antibiotic treatment became available. By way of example the
Tuskegee study resulted in numerous African American men dying from syphilis,
4. Oviedo Convention. Convention for the Protection of Human Rights and Dignity of the Human 
Being with regard to the Application of Biology and Medicine: Convention on Human Rights and 
Biomedicine, (1997). DOI: https://doi.org/10.1093/humrep/12.9.2076.
5. Cf. European Convention on Human Rights (ECHR). The Convention for the Protection of 
Human Rights and Fundamental Freedoms (4 November 1950), Article 5 § 1 (e). DOI: https://
doi.org/10.1093/law:epil/9780199231690/e790.
6. ACMP (n 1).
7. Oviedo Convention (n 4); ACMP (n 1).
8. Tribunals NM. The Nuremberg Code. 1947. Nuremberg Military Tribunals. DOI: https://doi.org/
10.1007/springerreference_300986.
9. Bernard A. Fischer, ‘A summary of important documents in the field of research ethics’ (2006) 32 (1) 
Schizophrenia Bulletin 69. DOI: https://doi.org/10.1093/schbul/sbj005.
10. Tribunals (n 8).
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women contracting the disease, and children born with congenital syphilis. Simi-
larly, from 1922–1953 medical doctors used marginalized patients as reservoirs to
facilitate malarial fever therapy for syphilitic patients by deliberately inoculating
them with malaria.11 Furthermore, other examples of unethical research outside
Nazi experiments have been described, among others, by Henry Beecher.12
1.3 Consent to research in psychiatry – codes of practices
Examples from history of unethical biomedical research conduct over time led to
codes of practices being agreed upon. The Nuremberg Code has been already
mentioned. Codes often are not legally binding instruments, but, rather, draw
authority from the codification in national legislation and from being generally
accepted standards in scientific communities, including international journals etc.
1.3.1 The Declaration of Helsinki 13 
The first version of this declaration was adopted in 1964 in Helsinki, Finland.
Afterwards, it has undergone several revisions. According to its Para 25, ‘Partici-
pation by individuals capable of giving informed consent as subjects in medical
research must be voluntary […]’.14 Furthermore, according to Para 30, research
involving patients who are ‘mentally incapable of giving consent […] may be done
only if the physical or mental condition that prevents giving informed consent is a
necessary characteristic of the research group’. In such situations, informed con-
sent must be obtained from a legally authorised representative (LAR).
1.3.2 Hawaii-declaration 15  
The prime declaration was adopted in 1977 at the 6th World Congress of Psychia-
try. A revised version was approved by the General Assembly of the World Psychi-
atric Association in 1983.16 The declaration explicitly stresses the necessity for
11. Matthew Gambino, ’Fevered Decisions: Race, Ethics, and Clinical Vulnerability in the Malarial 
Treatment of Neurosyphilis, 1922-1953’ (2015) 45 (4) The Hastings Center Report 39. DOI: https:/
/doi.org/10.1002/hast.451.
12. Henry Beecher, 'Ethics and clinical research' (1966) 274 (24) The New England Journal of Medicine 
1354. DOI: https://doi.org/10.4324/9781315244426-2.
13. Helsinki Declaration. World Medical Association Declaration of Helsinki: ethical principles for 
medical research involving human subjects. JAMA 2013;310(20):2191-4. DOI: https://doi.org/
10.1002/047086947x.oth1.
14. Helsinki Declaration (n 13).
15. Declaration of Hawaii. World Psychiatric Association ’Declaration adopted unanimously by the 
General Assembly of the World Psychiatric Association at the Sixth World Congress of Psychiatry’ 
(1977) 2 (6096) British Medical Journal 1204. DOI: https://doi.org/10.1136/bmj.2.6096.1204.
16. Declaration of Hawaii / II (approved by the General Assembly of the World Psychiatric Association 
in Vienna, Austria, on 10th July 1983).
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continuous research. At the same time, the declaration upholds that ‘No proce-
dure shall be performed nor treatment given against or independent of a patient’s
own will, unless because of mental illness, the patient cannot form a judgement as
to what is in his or her own best interest and without which treatment serious
impairment is likely to occur to the patient or others’ (Section 5).17 Importantly,
the declaration’s Section 9 declares that ‘To increase and propagate psychiatric
knowledge and skill requires [research] participation of the patients […]’ but ‘par-
ticipation must be voluntary, after full information […] and there must always be
a reasonable relationship between calculated risks or inconveniences and the ben-
efit of the study […]’. In situations where a patient cannot give informed consent,
it should be obtained from ‘the legal next-of kin’ and, in case of withdrawal from
participation, the psychiatrist's efforts to help the patient or subject may not be
influenced by this decision.
1.3.3 Belmont 18 
The Belmont report was issued in 1978 by the National Commission for the Pro-
tection of Human Subjects of Biomedical and Behavioral Research and prompted
in part by the Tuskegee Syphilis Study. The report identities three core principles
(respect for persons, beneficence, and justice) and three primary areas of applica-
tion (informed consent, assessment of risks and benefits, and research subject
selection).19 Specifically, about ‘Voluntariness’ the report maintains that an agree-
ment to participate in research only constitutes a valid consent if it is voluntarily
given thereby requiring ‘conditions free of coercion and undue influence’. Coercion
is narrowly defined in terms of overt and intentional threat of harm in order to get
compliance.20 Regarding research in vulnerable populations, the report upholds
the principle that ‘other less burdened classes of persons should be called upon
first […] except where the research is directly related to the specific conditions of
the class involved […]’. Similarly, it is crucial that ‘very sick, and the institutional-
ized’ patients who frequently lack capacity for free consent should not be involved
17. Declaration of Hawaii / II (n 16).
18. Belmont Report. National Commission for the Protection of Human Subjects of Biomedical and 
Behavioral Research. Ethical Principles and Guidelines for the Protection of Human Subjects of 
Research (the Belmont Report). Belmont Conference Center, Elkridge, Maryland: The National 
Commission for the Protection of Human Subjects of Biomedical and Behavioral Research; 1979. 
DOI: https://doi.org/10.1007/978-1-4020-5614-7_233.
19. Justin C. Strickland and William W. Stoops 'Perceptions of research risk and undue influence: 
Implications for ethics of research conducted with cocaine users' (2015) 156 Drug and Alcohol 
Dependence 304. DOI: https://doi.org/10.1016/j.drugalcdep.2015.09.029.
20. Belmont Report (n 18).
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in research because they are easy to manipulate as a result of, e.g., illness or for
administrative convenience.
1.3.4 The Oviedo Convention 21 
This international treaty, issued by the Council of Europe, is an international legally
binding instrument in the field of biology and medicine. Basically, it draws on the
principles established by the European Convention on Human Rights and aims at
protecting the dignity and identity of all human beings and at guaranteeing that
everyone, without discrimination, should have respect for their integrity and other
rights and fundamental freedoms. It deals specifically with biomedical research,
genetics and transplantation but also sets out fundamental patients’ rights applicable
to daily medical practice.22 The convention is signed and ratified by Denmark and
Norway. Sweden has signed the convention, but not ratified it, while it is not signed by
the UK.23 The convention maintains the ‘General rule’ that ‘An intervention in the
health field may only be carried out after the person concerned has given free and
informed consent to it […] The person concerned may freely withdraw consent at any
time’ (Article 5). Regarding ‘Protection of persons not able to consent’, it should be
noted that the convention allows for intervention if it is ‘for his or her direct benefit’
(Article 6). Likewise, if incapacity for consent is caused by mental disability or for sim-
ilar reasons, ‘the intervention may only be carried out with the authorisation of his or
her representative or an authority or a person or body provided for by law […]’.24
Specifically, regarding ’Scientific research’, the convention’s article 16 sets forth
criteria for protecting persons undergoing research.25 Hence, it is stated that research
involving human beings may only be conducted if a number of conditions are met.
First, it is a requirement that there is no alternative of comparable effectiveness to
conducting the study in humans (i). Second, the risks are not disproportionate to
the potential benefits of the study (ii). The research project must also be approved
by a competent body after independent examination of the project’s scientific
merit, the importance of the research project, and its ethical acceptability from a
multidisciplinary perspective (iii). Furthermore, individuals included in the study
must be informed of their rights and safeguards prescribed by law (iv). Finally, it is
21. Oviedo Convention (n 4).
22. Bioetikkonventionen. [Bekendtgørelse af Europarådets konvention af 4. april 1997 om menneske-
rettigheder og biomedicin], (2000).
23. For a chart of signatures and ratifications, see https://www.coe.int/en/web/conventions/full-list/-/
conventions/treaty/164/signatures?p_auth=2wabmvff.
24. Oviedo Convention (n 4).
25. Oviedo Convention (n 4).
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maintained as a requirement that the necessary consent as provided for under
Article 5 has been given.
In article 17, about ‘Research on a person without the capacity to consent’ it is
stated that such research ‘may be undertaken only’ if the conditions laid down in
Article 16, sub-paragraphs i to iv mentioned above are fulfilled. It is mandatory
that ‘the results of the research have the potential to produce real and direct bene-
fit to his or her health’ (i). Also, it is a prerequisite that ‘research of comparable
effectiveness cannot be carried out on individuals capable of giving consent’ (ii).
Furthermore, the necessary authorisation provided for under Article 6’ must have
been given specifically and in writing (iii) and it also is a precondition that ‘the
person concerned does not object’ (iv). However, if ‘the research has not the
potential to directly benefit the person concerned’, it can be authorised only in
exceptional circumstances if it aims to contribute ‘through significant improve-
ment in the scientific understanding of the individual's condition, disease or dis-
order, to the ultimate attainment of results capable of conferring benefit to the
person concerned or to other persons in the same age category or afflicted with
the same disease or disorder or having the same condition’ (i) and there must be
only minimal risk and burden for the research individual (ii) (cf. Article 17).26
1.3.5 United Nations’ Convention on the Rights of Persons with Disabilities 27 
The UN Convention on the Rights of Persons with Disabilities (CRPD; 13 Decem-
ber) 2006 is ratified by the European Union and is intended as a human rights
instrument which reaffirms that persons with all types of disabilities must enjoy all
human rights and fundamental freedoms. All states that are part of this study have
ratified it. It adopts a broad categorization of persons with disabilities and will
include psychiatric patients. In the context of the present analysis, the convention’s
articles 12 and 14 deserve mention. About ‘Equal recognition before the law’, Article
12 declares that ‘States Parties shall recognize that persons with disabilities enjoy
legal capacity on an equal basis with others in all aspects of life’ (2). The provision in
Article 14 about ‘Liberty and security of person’ maintains that ‘States Parties shall
ensure that persons with disabilities, on an equal basis with others: a) Enjoy the right
26. Oviedo Convention (n 4).
27. The UN Convention on the Rights of Persons with Disabilities (December 13) 2006. DOI: https://
doi.org/10.1163/9789004220829_010. Please also see General Comment No.1 (2014) and Guide-
lines on the right to liberty and security of persons with disabilities (see, e.g., Supplement No. 55 
(A/72/55) in Report of the Committee on the Rights of Persons with Disabilities; Sixteenth session, 
15 August-2 September 2016). For a critical discussion of Article 12, please see Lile, Hadi. (2019). 
Paradigmeskifte eller villedende aktivisme?. Kritisk juss. 45. 49-56. https://doi.org/10.18261/
issn.2387-4546-2019-02-01.
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to liberty and security of person [...]’. The CPRD committee’s ‘General Comment’
regarding Article 12 explicitly states that having a disability (in this context mental
disorder) is not a reason to take away persons’ right to make their own decisions.
Similarly, reference can be made to the convention’s Article 5 protecting equal-
ity and non-discrimination. This article maintains states’ duty to ‘recognize that
all persons are equal before and under the law and are entitled without any dis-
crimination to the equal protection and equal benefit of the law’. Furthermore, the
convention’s Article 25 states that persons with disabilities have the right to the
enjoyment of the highest attainable standard of health without discrimination on
the basis of disability.
As it appears above, there appears to be no general prohibition in international
instruments regarding research involving patients subject to psychiatric coercive
measures. Instruments rather point to the necessity for treatment and research
given the premise that the project has been approved by an ethics committee and
that the patient does not object to research participation. When patients seem
incapable of decision making, instruments recommend obtaining consent from a
legally authorised representative. The position mentioned above may, however, be
differently reflected in various countries. The law in Norway, Sweden, and UK is
described below, followed by a description of the situation in Denmark.
2 Case studies – Legislation on coercion and clinical research in 
neighbouring countries
2.1 Norway – Clinical research in psychiatric patients subject to coercive measures 
Clinical research within the health care sector is regulated by the Health Research
Act.28 According to Section 9 every research project within the scope of the act
must be approved in advance by the regional committee for Medical and Health
Research Ethics, (cf. Section 10 of the Ethics and Integrity in Research Act).29 The
legal framework concerning research on patients with limited capacity to consent
is based on the Oviedo convention.30
28. Health Research Act. Act (20 June 2008 No. 44) on Medical and Health Research; Regulations and 
legal material is accessible at https://lovdata.no/info/information_in_Norwegian (accessed 1 
February 2020) and the database is partly free of charge. A selection of legal material translated into 
English is available at http://www.ub.uio.no/ujur/ulov/ (accessed 1 February 2020) but note that not 
all regulations are translated and that they are not always up to date. For an introduction to Norwe-
gian health law in general, see Karl Harald Søvig, Medical Law – Norway, suppl. 92, ed. Herman 
Nys (Wolters Kluwer 2019).
29. Act 28 April 2017 No. 23 on ethics and integrity in research.
30. See the presentation of the Oviedo Convention in the ministry’s proposition to the parliament, cf. 
Ot.prp. No. 74 (2006–2007) p. 89 (this proposal was submitted prior to Norway’s ratification of CRPD).
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As a general rule, consent must be obtained from participants in medical and
health research, unless otherwise laid down in law, cf. Section 13. This general rule
also applies to psychiatric patients, even if they are subject to coercive measures.
This approach ensures that vulnerable patient groups are not automatically
excluded from medical research, although safeguards are present. As for all
research participants, consent must be ‘informed, voluntary, express and docu-
mented’, (cf. the Health Research Act Section 13, second paragraph).31 Capacity to
consent is regulated by Section 17. According to the first paragraph, all persons
above the age of 18 years may give consent, unless they are deprived of legal capac-
ity in private matters according to the Guardian Act Section 22 (the provisions
concerning minors are not dealt with here).32 The competence to consent pursu-
ant to the first paragraph ‘may cease to apply’ in the situations referred to in Sec-
tion 4-3, second paragraph of the Patient Rights Act.33 As a result, capacity to give
consent does not cease to exist as an automatic consequence of being admitted to a
psychiatric ward, even if the hospitalization is involuntary. An assessment of the
patient’s ability to understand the consequences of an actual research project is
required.
If the person concerned is not able to consent, the person’s next-of-kin has
authority to grant consent, cf. Section 17, fifth paragraph of the Health Research
Act. In such situations, Section 18 introduces further conditions for medical
research. The ‘potential risks or disadvantages for the person’ must be ‘insignifi-
cant’ (litra a) and there must be ‘reason to assume that the results of the research
may be of use to the person concerned or other people with the same age-specific
disorder, disease, injury or condition’ (litra c). Additionally, the individual
involved must not be opposed to the intervention (litra b). It is also a requirement
that there is no reason to believe that the person concerned ‘would have been
averse to participating in the research project if they had had the capacity to give
their consent’, and that ‘ ‘similar research cannot be done on people who have the
capacity to give consent’, cf. Section 18, third paragraph. The responsibility vested
both with the ethics committee and the researchers must be emphasised. The
regional committee has to make an assessment that the research project has suffi-
cient quality to be carried out on such a vulnerable group and the individual
researcher has to evaluate the involvement of each individual patient. If the
research participant can be regarded as ‘being in a relationship of dependency
with the person requesting consent’, meaning that the research participant might
31. Health Research Act (n 28).
32. Guardianship Act. The Act of 26 March 2010 No. 9 relating to Guardianship.
33. Patient Rights Act. The Act of 2 July 1999 No. 63 relating to Patients' Rights.
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feel pressured to give their consent, informed consent must be obtained from
another person with whom the research participant does not have this kind of
relationship, cf. Section 13 third paragraph.
For some specific situations, special regulations apply. Testing of medical prod-
ucts (including drugs) is governed by a separate regulation that implements EU
law, and conditions are similar to those of other medical research.34 However, the
limitations are more detailed. Inter alia, the results of the research must be directly
beneficial to the trial person’s health. The Health Research Act also contains a pro-
vision concerning research in clinical emergencies, (cf. Section 19).35 Additionally,
the Act contains provisions concerning the use for research purposes of health
information collected by the health service in connection with diagnosis and
treatment, cf. Sections 28 and 35. Here the regional committees can authorize
research without the consent of the patient if the research in question is of ‘signifi-
cant interest to society’ and the ‘participants’ welfare and integrity are ensured’. In
all these situations, psychiatric patients subject to coercive measures are regarded
in the same manner as other patients. However, the fact that they are in an invol-
untary situation, may impact the assessment. For example, research on blood sam-
ples from patients in a locked ward will normally not be authorized since use of
data from involuntary patients will violate their integrity.36 There are few reported
court cases regarding research on patients’ subject to coercive measures within
psychiatric care.37,38 An expert committee submitted a draft for a new act concern-
ing psychiatric care but the proposal does not include provisions regarding
research.39
34. Regulation relating to clinical trials on medicinal products for human use (No. 1321, 30 October 
2009) and EU directive 2001/20 (to be repealed by Regulation EU No 536/2014). Norway is not a 
member of the European Union but is affiliated to the European Union and its member states by 
the European Economic Area (EEA-agreement). Based on the EEA-agreement, the three EFTA 
countries (Iceland, Lichtenstein and Norway) participate extensively in the internal market and is 
bound by the relevant EU legislation. For an in-depth analysis of the EEA agreement, see Finn 
Arnesen et al., Agreement on the European Economic Area: A Commentary (Nomos/Hart 2018).
35. Health Research Act (n 28).
36. Cf. decision by the National Committee for Medical and Health Research Ethics in an appeal case 
concerning serum concentration of lipids and drugs amongst patients receiving antipsychotic treat-
ment, cf. case 2013/174.
37. The case decided by the Supreme Court in Rt. 1994 p. 691 concerns the use of information from 
medical records.
38. ECHR (n 5), article 8.
39. NOU 2019:14 Tvangsbegrensningsloven.
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2.2 Sweden – Clinical research in psychiatric patients subjected to coercive 
measures (incl. non-voluntary hospitalization). 
In Sweden, the general regulation dealing with vetting the ethics of research
involving living persons is the Ethical Review Act (ERA).40 According to this regu-
lation, such research must meet certain general criteria regarding information and
consent to participate. A central starting point is that research should be allowed
only if the risks and the discomfort, that research persons may be exposed to, are
in reasonable proportion to the knowledge gain that the study is expected to pro-
vide.41 In other words, there must be an acceptable relationship between risk and
benefit. The ERA aims to protect the people who in various ways participate in
research and seek to ensure protection by requiring that some research must be
tested and approved prior to commencement based on certain criteria. The assess-
ment is based on a balancing of interests and does not mean that privacy infringe-
ment can be ruled out. A research project can be approved only in those cases
where the risk of health, security and privacy violation is outweighed by the scien-
tific value and gains of the project. According to the ERA, research can only be
approved if it can be carried out with respect for human dignity.42 Furthermore,
human rights and fundamental freedoms must always be taken into account in the
ethical review.43 According to this legislation, the research person must be
informed about the overall plan for the research, the purpose of the research, the
methods that will be used, the consequences and risks that the research may
entail, the identity of the principal investigator or of the project, and that partici-
pation in the research is voluntary, and that the research person can cancel his or
her participation at any time.44 The Act further states that the research project may
only be carried out if the research person has agreed to participate and received
information about the research.45
The regulation also sets certain specific restrictions for conducting research on
people with limited decision-making capacity. This kind of research may be car-
ried out only if it can be expected to provide knowledge that cannot be obtained
through research in people following consent achieved through usual procedures.
Furthermore, research should be expected to directly benefit the participating,
individual patient (section 21). Alternatively, according to the same section, the
40. Ethical Review Act, ERA (2003:460). The Act concerning the Ethical Review of Research Involving 
Humans (SFS 2003:460).
41. ERA (n 40), Para 9.
42. ERA (n 40), Para 7.
43. ERA (n 40), Para 8.
44. ERA (n 40), Para 16.
45. ERA (n 40), Para 17.
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project can be carried out if a) the purpose is to contribute to a result that can be
of benefit to someone else suffering from the same or similar illness or disorder,
and b) the research involves an insignificant risk of injury and only a slight dis-
comfort for the research person. However, the Medical Products Act (MPA) puts
some further restrictions on clinical trials in psychiatric patients subjected to
coercive measures.46 According to this legislation (lex specialis), clinical drug test-
ing which is not related to a patient’s disease treatment may not be conducted on
patients subjected to psychiatric coercive measures under the Compulsory Mental
Care Act and the Forensic Mental Care Act.47
Thus, there are certain specific restrictions concerning research involving this
group of patients but no absolute ban. Any intervention tested must have a con-
nection to the disease treatment given to the person in psychiatric coercive care.
In addition, the general conditions for doing research in humans stated above
must always be assessed by the ethical review boards.48 Therefore, the extent to
which clinical trials, qualitative research, non-drug trials or any other type of par-
ticipation in research with persons subjected to coercive measures may get
approval by the ethical review board is carefully scrutinized on a case by case
basis. The only regulated limitation for research persons subjected to psychiatric
coercive measures specifically is in the MPA which puts a ban on clinical drug
testing which is not related to a patient’s disease treatment.
2.3 United Kingdom – Clinical research in psychiatric patients subjected to 
coercive measures 
The United Kingdom consists of England, governed by Westminster and the
devolved administrations of Wales, Scotland and Northern Ireland (NI). Most UK
law governing compulsory treatment for mental disorder consists of specific men-
tal health legislation (the Mental Health Act in England and Wales, and the Mental
Health Care and Treatment Act in Scotland).49,50 In NI, a different approach has
been taken and mental disorder is managed through more general capacity legis-
lation,51 rather than legislation specifically for mental disorder. The two UK Men-
tal Health Acts have some differences, but their primary intention is to govern the
46. Medical Products Act (2015:315).
47. Compulsory Mental Care Act (1991:1128) Chapter 7 Para 5. See also Forensic Mental Care Act 
(1991:1129).
48. ERA (n 40).
49. Mental Health Act 1983 (c. 20).
50. Mental Health (Care and Treatment) (Scotland) Act 2003 asp 13. Act of the Scottish Parliament to 
restate and amend the law relating to mentally disordered persons, and for connected purposes.
51. Mental Capacity Act (Northern Ireland) 2016 (c. 18).
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assessment, treatment, and rights of people with a mental health disorder. To be
detained under the Mental Health Act a person must be deemed to need urgent
treatment for a mental health disorder and be at risk of harm to either themselves
or others. These Mental Health Acts do not govern participation in research as this
is generally deemed an issue for capacity legislation.
UK law relating to capacity (with exception of NI) is set out in England and
Wales by the Mental Capacity Act52 and in Scotland by the Adults with Incapacity
Act.53 In general, capacity is presumed to exist, unless there is evidence of its
absence, and is seen as being task specific. Capacity depends on the decision the
individual is making and their cognitive functioning at the time of making the
decision; therefore, a person may be detained under a section of the Mental Health
Act but still be deemed to have capacity to participate in research. The decision
about the capacity of an individual within a mental health inpatient setting to take
part in research is determined by the clinical staff and not by the study researchers.
The Health Research Authority (HRA) is responsible for regulating health
research in England, in partnership with each of the devolved administrations.54
Part of the HRA is the UK Research Ethics Service, a structure of local Research
Ethics Committees in England that provide ethical approval for UK research and
clinical trials.55 It is a UK-wide legal requirement that any research that involves
patients must be reviewed by Research Ethics Committees. This review includes
ensuring procedures in line with legislation are in place for participants who are
deemed to lack capacity. Generally, when an individual lacks capacity, the decision
to include them in the research must be informed by the potential risks and bene-
fits of participation, and the potential benefit must outweigh any risks, particu-
larly in the case of clinical trials. If there are no direct benefits, then the risks
should also be negligible. If it is at all possible, participation should be discussed
with the individual in such a way as to maximise comprehension of the proposed
participation.
Participation in research for patients lacking capacity is governed either by
capacity legislation or the Medicines for Human Use Regulations 2004, depending
on whether the study is a clinical trial or not. In clinical trials in England and
Wales, Scotland and NI a legal representative can give consent on behalf of an
adult lacking capacity. They can be a ‘personal’ legal representative (unconnected
with the clinical trial who is appropriate to act due to their relationship with the
52. Mental Capacity Act 2005 (c. 9).
53. Adults with Incapacity (Scotland) Act 2000 asp 4.
54. UK Policy Framework for Health and Social Care Research.
55. Governance arrangements for research ethics committees: 2018 edition.
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adult. If there is not a personal legal representative available, a ‘professional’ legal
representative (e.g. a doctor unconnected with the trial) can give consent. In Scot-
land a personal legal representative can be a Welfare Guardian, Welfare Attorney
(roles within the AWISA) or the Nearest Relative (role under the Mental Health
Care and Treatment Scotland Act 2003). If these are not available, then a profes-
sional legal representative can give consent. The legal representative must be
aware they are consenting, free to make the decision, be given adequate informa-
tion, and consider what the adult would want before they make a decision. The
adult lacking capacity must also be given information about the trial in line with
their presumed understanding.
For non-clinical trials in England and Wales the Mental Capacity Act is used
and a ‘consultee’ is asked for an opinion on whether an adult lacking capacity
would want to take part in the research. Consultees can be personal or legal.
A personal consultee can be an informal carer or someone else with an interest in
their welfare in an unpaid role. If there is no personal consultee available, then a
nominated consultee can be a professional as long as they are independent of the
research. Consultees must be given information about the study, asked what views
the person would have, and their decision recorded on a declaration form (rather
than a consent form). The participant must also be given information about the
study. In Scotland a non-clinical trial still requires a personal legal representative
that must be a Welfare Guardian or Welfare Attorney or nearest relative. Again,
they must be given information, asked to decide on behalf of the adult (not their
own views) including taking into account whether the adult has expressed any
view about the research. There is no specific legislation in NI governing the con-
duct of non-clinical trials although all research must be approved by a research
ethics committee and be in line with the principles of common law.
Although there is no automatic bar on people subject to the mental health act
taking part in research, the complexity of the UK regulatory framework is thought
to have led to researchers avoiding carrying out research with people who are risk
of having lost capacity. This risks a lack of research that in turn limits improve-
ments in care and treatment for certain groups of the population.56
56. Shepherd, V. (2016). Research involving adults lacking capacity to consent: the impact of research 
regulation on ‘evidence biased’ medicine. BMC Medical Ethics, 17(1), 55. DOI: https://doi.org/
10.1186/s12910-016-0138-9.
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3 The Danish situation – Current Danish legislation on coercion 
and clinical research
3.1 Danish psychiatry law 
As a general rule, according to the Danish Health Care Act, ‘No treatment may be
commenced or continued without the patient’s informed consent, unless in
accordance with law […]’.57 Achieving the patient’s informed consent and patient
participation (e.g. in connection with a shared decision-making process) mirrors
the bioethical principle of respect for healthcare users’ autonomy. Informed con-
sent requirements likewise mirror the principle of liberty stated in the Danish
Constitutional Law.58 Danish psychiatric law upholds informed consent principles,
but in psychiatry, the use of coercive measures in some situations is legalised
through the Act on Coercive Measures in Psychiatry (ACMP).59 ACMP sets forth
the legal requirements for involuntary admission to public psychiatric hospitals
and the use of coercive measures during admission. Among coercive measures,
are, e.g., mechanical restraints in terms of belt, hand, foot straps and gloves, and
sedating injections if considered necessary for ‘relieving the state of a very dis-
tressed patient’.6061 In any case, there is a requirement for using the least intrusive
measure.62
A separate statute governs participation in health research. The Danish Act on
Research Ethics Review of Health Research Projects (DARER) requires health
research projects other than register-based studies, or research based on records,
interviews, or questionnaires, to be approved by an Ethics committee.63 However,
specifically regarding patients subject to coercive measures, the ACMP sets out
specific rules stating that ‘Patients who are subject to coercive measures according
to the Act may not be subjected to experimental treatment’ and that ‘Experimental
treatment may not be instituted using coercion in voluntarily admitted patients’.64
This has led to patients subject to coercive measures being excluded from partici-
pation in research involving any kind of intervention. The background and legal
situation are described in further detail below.
57. DHA (n 2), Para 15; Birkeland and Gildberg (n 3).
58. Danish Constitutional Law (Grundloven; Para 71). According to Para 71, restriction of liberty can-
not be instigated without a legal basis.
59. ACMP (n 1), Paras 5, 10, 12.
60. ACMP (n 1), Para 14.
61. ACMP (n 1), Para 17.
62. ACMP (n 1), e.g. Paras 3, 4 and 11.
63. DARER. Danish Act on Research Ethics Review of Health Research Projects, [Lov om videnskabs-
etisk behandling af sundhedsvidenskabelige forskningsprojekter], (2011), Paras 13 and 14
64. ACMP (n 1), Para 23.
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3.2 History of the Danish model on coercion and clinical research – 
the Mental Health Care White Paper (MHCWP).65
In the white paper preceding the ACMP,66 an entire chapter is devoted to the topic
of conducting research when patients undergo coercive measures. MHCWP reca-
pitulates that according to the former ‘Act on Mentally Disordered Inpatients’ no
specific legislation existed on the issue and, when considering involvement in
research, psychiatric patients were equally treated with other patients. Research
projects, therefore, needed prior approval from a medical ethics board. Com-
plaints related to research projects were handled by the Danish National Board of
Health.
MHCWP initially maintains that there is essentially no difference between the
need for patient involvement in psychiatric care and other health care. Regarding
psychiatric patients under coercion, however, MHCWP maintains that a substan-
tial difference arises when obtaining valid informed consent to research participa-
tion. MHCWP refers to the European Council Recommendation (ECR) concern-
ing the legal protection of persons suffering from mental disorder.67 In the ECR’s
Article 5 (2), it is stated that: ‘A treatment which is not yet generally recognised by
medical science […] may be given only if the doctor considers it indispensable
and if the patient, after being informed, has given his express consent’. In those sit-
uations where a ‘patient is not capable of understanding the nature of the treat-
ment, the doctor should submit the matter for decision to an appropriate inde-
pendent authority prescribed by law which should consult the patient’s legal repre-
sentative, if any’. Likewise, ECR maintains that if applying drugs, etc. without the
aim of psychiatric treatment, ‘clinical research should not be permitted in psychi-
atric patients subject to coercive measures. But in case of purpose of psychiatric
treatment, every country should decide whether research should be permitted’.
Reference then is made to a Swedish white paper stating that ‘treatment provided
to patients subject to coercive measures should always come up to at least com-
monly acknowledged scientific standards’.68 From the latter, MHCWP makes the
remarkable inference that research generally should not be permitted on patients
subject to coercion.
65. MHCWP. Mental Health Care White Paper. Justitsministeriet. Principbetænkning nr. 1068 (1986) 
om tvang i psykiatrien. Afgivet af det af justitsministeriet nedsatte udvalg vedrørende sindslidendes 
retsstilling. Copenhagen; 1986.
66. MHCWP (n 65), page 376.
67. ECR. European Council Recommendation N. 2 concerning the legal protection of persons suffe-
ring from mental disorder placed as involuntary patients (Adopted by the Committee of Ministers 
on 22 February 1983 at the 356th meeting of the Ministers’ Deputies).
68. Socialdepartementet. Psykiatrien, Tvånget och rättssäkerheten – Betænkanda av Socialberedningen. 
Stockholm: Socialdepartementet SOU. 1984:64 page 250.
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MHCWP underscores that a patient’s participation in a research project
requires his or her informed consent as well as an adequate proportionality
between the project’s supposed risk, adverse effects, discomfort, and scientific
value.69 MHCWP naturally upholds that patients in clinical research should be
able to refuse to participate in or withdraw from research without any adverse
influence on their care and treatment. MHCWP then argues that there is no rea-
son for further defining the concept of experimental treatment although it covers
clinical research including drug trials as well as testing other ‘new measures’ for
the entire or partial reason of a research purpose. The MHCWP does not question
that ‘Such new measures undoubtedly are important and desirable from the point
of view of patients as well’ but in any case makes the inference that new measures
should ‘be only given to voluntarily admitted patients following an informed con-
sent and never to individuals subjected to coercion’. The latter is reasoned by the
circumstance that patients who are admitted involuntarily ‘have a dependency
relationship with the senior consultant making it very difficult to establish the vol-
untariness of any consent’. It is stressed that reflections do not intend to indicate
that a senior consultant would put pressure on the psychiatric patient in order to
make him or her participate. According to MHCWP, reflections mirror a worry
that some patients would falsely believe that consent could accelerate coercive
measure termination or discharge from hospital. MHCWP concludes that ensur-
ing against such beliefs would be so difficult that it is generally required to pro-
hibit participation of psychiatric patients subject to involuntary admission in any
kind of ‘experimental treatment no matter the form of the treatment and its pur-
pose and irrespective of any informed consent stated by the patient’.70 The argu-
mentation is notable but not necessarily very convincing. At least it is doubtful
whether the argument is convincing enough to deter a patient’s wish to actually
participate in a study where he or she may contribute to better future care for the
patient him- or herself and for other patients (see below). It is remarkable that the
other contents of the 1983 European Council Recommendation received virtually
no attention in MHCWP, including the Recommendation’s Article 5, subsection 1,
stating that ‘A patient put under placement has a right to be treated under the
same ethical and scientific conditions as any other sick person […]’.
69. MHCWP (n 65).
70. MHCWP (n 65). Please note that in Danish law, although a psychiatric patient is voluntarily admit-
ted, criteria for involuntary admission must be met if, e.g., mechanical restraints are used for hours 
(Soren Birkeland, 'Iværksættelse af psykiatrisk tvangsfiksering:lovgivning og retspraksis', Juristen 
nr. 6 2015 page 210). Also, if a voluntarily admitted patient demands to be discharged, the patient 
must be detained if coming up to criteria for unvoluntary admission (ACMP Paras 5 and 10).
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3.3 The Danish Act on Research Ethics Review of Health Research Projects71
It is noteworthy that the major formal legislation relating to biomedical research,
DARER, does not itself address research involving patients subject to psychiatric
coercive measures. With reference to the latter act, however, Ministerial Orders on
Research Ethics Review of Health Research Projects have been issued. In the 2011
Ministerial Order version, it is repeatedly stressed that ‘Persons subject to coer-
cion according to the Act on Psychiatric Coercive Measures cannot participate in
biomedical research projects, cf. Para 23 (1)’ thereby referring to the ACMP.72 The
wording of the ACMP Para 23 has been unchanged since its introduction. How-
ever, in 2012 DARER replaced the earlier ‘Danish Act on Research Ethics Review of
Biomedical Research Projects’.73As it is clear from its title, a change in terminology
from ‘Biomedical Research Projects’ to ‘Health Research Projects’ was thereby intro-
duced. Even though the former act did not explicitly address research in psychiat-
ric patients, the change in scope to ‘Health Research Projects’ was followed by a
revision of the accompanying Ministerial Order. As of the revision, patients sub-
ject to coercion according to ACMP were not only prohibited from participating
in biomedical research, but generally could not ‘participate in health research pro-
jects’ (please see Ministerial order 538, Para § 10, section 2).74 Hence, projects
involving psychosocial and non-pharmaceutical interventions which are beyond
the narrow area of biomedical testing became prohibited.75 In the bill preceding
the 2012 revision, it was stated that ‘Persons who are subject to detention or com-
pulsion in psychiatry cannot participate as test subjects, cf. Pare 23 of the
[ACMP]’. However, the bill made no distinction between ‘biomedical research
projects’ and projects with psychosocial and non-pharmaceutical interventions.
Apparently, without any further deliberation, all kinds of health research involving
patients subject to coercion as ‘test subjects’ were prohibited through the Ministe-
rial Order’s direct reference to ACMP.
71. DARER (n 63).
72. Ministerial Order 2011. Ministerial Order on Research Ethics Review of Biomedical Research 
Projects [Vejledning om anmeldelse m.v. af et biomedicinsk forskningsprojekt til det videnskabs-
etiske komitésystem], (2011).
73. Danish Act on Research Ethics Review of Biomedical Research Projects (see, e.g., [Bekendtgørelse 
af lov om et videnskabsetisk komitésystem og behandling af biomedicinske forskningsprojekter] 
nr. 69, dated 08/01/1999).
74. Ministerial Order 538. Ministerial Order on Research Ethics Review of Health Research Projects 
[Bekendtgørelse om information og samtykke til deltagelse i sundhedsvidenskabelige forsknings-
projekter samt om anmeldelse af og tilsyn med sundhedsvidenskabelige forskningsprojekter], 
(2012).
75. Still, research only involving questionnaires and interviews, or register-based studies would be per-
mitted.
BIRKELAND, BERZINS, BAKER, MATTSSON, SØVIG AND GILDBERG
20
The ban has some wide-ranging consequences. To illustrate this, let us imagine a
research project aiming to investigate methods to reduce mechanical restraint
(MR) duration through conflict-management that must be considered a non-phar-
maceutical intervention. When considering the pros and cons of research partici-
pation from a patient’s perspective, this kind of project might imply a risk of pro-
longed restraint, no effect, or shortened restraint. According to law, however, pro-
longed restraint still should be averted by the legal obligation to MR release when
legal criteria are no longer met. Contrarily, an overly shortened MR duration may
possibly result in patient retaliation and pose a risk to staff safety. This would be
countered by the customary safety procedures following MR use (e.g. intensive
patient observation). From the perspective of the Nuremberg code (see above), a
major intention was to ensure that scientific experiments on patients would never
again be allowed against the patients’ will. A total ban on research on patients sub-
ject to coercion, of course, will totally prevent the problem from arising. However,
by not allowing any healthcare intervention studies even when major ethical pitfalls
are addressed, both patients and clinical practice seem deprived of the much-
needed potential for evidence-based improvement. In our imagined research pro-
ject, participants may suffer from psychosis, or the patient’s ‘free power of choice’
potentially can be challenged through ‘force, fraud, deceit, duress, over-reaching, or
other ulterior form of constraint or coercion’ (cf. Nuremberg Code). This, however,
could be counteracted by mandatory prior evaluation by an independent board and
requirement for obtaining consent from a LAR (see above). MR is one of the most
intrusive of all psychiatric coercive measures and its use in Denmark has already
been repeatedly criticized and referred to as amounting to ill-treatment by the
European Committee for the Prevention of Torture and Inhuman or Degrading
Treatment or Punishment (CPT).76,77,78 One might provocatively argue that current
legislation allows for the continuation of objectionable practices while prohibiting
any initiatives towards evidence-based MR use reductions.
Other examples would be clinical trials with patients that are involuntarily
admitted but are given a new antipsychotic medication or clinical trials with
patients that are subject to involuntary medication. In the first example, many
76. Birkeland and Gildberg (n 3).
77. Report to the Government of Denmark on the visit to Denmark carried out by the European 
Committee for the Prevention of Torture and Inhuman or Degrading Treatment or Punishment 
(CPT), Strasbourg, 2008.
78. Report to the Government of Denmark on the visit to Denmark carried out by the European 
Committee for the Prevention of Torture and Inhuman or Degrading Treatment or Punishment 
(CPT), Strasbourg, 2012. The CPT upholds that “The maximum duration of the application of 
mechanical restraint should ordinarily not exceed 6 hours’.
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would argue that such patients should be allowed to participate if they seem of
‘sound mind’ to consent, and research could not be meaningfully carried out with-
out their participation. Contrarily, in the other example, some might be more
sceptical, while the patient simply does not consent to medication at all. Examples
reflect underlying nuances that current Danish legislation does not address.
Because of the need for evidence-based interventions, clinical practice has
found other options. One way is ‘evaluation research’. While research with inter-
ventions is not allowed, clinicians can implement interventions and afterwards
‘may wish to evaluate effects’. However, this solution is a slippery slope as, e.g., no
patient consent is required for this kind of ‘hidden clinical research’ that therefore
may also tend to be an unlawful circumvention of ACMP.
4 Some fundamental questions 
4.1 The problem with voluntariness in non-voluntary settings
Above, the problem with respecting patients’ right to self-determination in regard
to research participation when subject to compulsion has been recurrently
described. Taken as a whole, however, the question can be raised whether it makes
sense to seek consent to participation from an individual whose presence in the
psychiatric hospital is involuntary. The problems with obtaining valid consent,
obviously, are accentuated in forensic psychiatry or prison settings etc.79 Still, the
Nuremberg Code and the Belmont report perhaps most specifically address the
type of problem with obtaining ‘voluntary consent’ in persons potentially unable to
exercise free power of choice due to the ‘element of force’ or ‘other ulterior form of
constraint or coercion’ (see above). The question of ‘voluntariness’ vs. ‘non-volun-
tariness’ may not be as black and white as it seems, though. Hewlett previously
emphasized that all decisions to participate in research ‘are made within the con-
text and influence of people or circumstances’.80 Thus, she argues that in clinical
research, consent by patients must often be only ‘partially voluntary’, as ‘it lies
within the context of illness or the doctor/patient relationship’. As a result, the duty
of the health care researcher would be to ensure that this partially voluntary con-
sent is ‘adequately voluntary’ as is the case in usual clinic decision-making, and
ensuring that a patient is adequately informed before his or her consent is
obtained. Perhaps we may a little provocatively argue that the decision on research
79. Paul G. Stiles, Monica Epstein, Norman Poythress, John F. Edens, 'Protecting people who decline to par-
ticipate in research: an example from a prison setting' (12) 34 (2) IRB Ethics and Human Research 15.
80. Sarah Hewlett, ‘Consent to clinical research—Adequately voluntary or substantially influenced?’ 
(1996) 22 (4) Journal of Medical Ethics 232. DOI: https://doi.org/10.1136/jme.22.4.232.
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participation must be free of coercion – but not necessarily of the background set-
ting. In line with soft law recommendations mentioned above, Hewlett proposes a
number of ways to ensure that consent is valid; for example, the use of independ-
ent, trained, and research ethics committee employed advocates. About the ‘dual
role’ dilemma (caring for patients while also serving the public good) this problem
in many instances can be solved with a rule requiring that the person asking for
enrolment in the research project must be other than the person responsible for
the treatment. Correspondingly, in their discussion of ‘The Concept of Voluntary
Consent’, Nelson and colleagues problematize the use of ‘coercion’ as a term.81 The
authors point out that patients may sometimes feel fear of losing health care bene-
fits, regardless of their powers of resistance to any such influence and whether
there is a genuine threat. They argue that coercion necessitates an intention to
coerce. However, irrespective of not being ‘coerced’, the authors argue that many
patients may feel heavily pressured to enrol in clinical trials and this kind of pres-
sure may be felt as intensely as in truly coerced persons. Similarly, ‘offers of prom-
ising “treatments” that are primarily research investigations can leave a person
with a sense of having no meaningful choice’. The authors point to the fact that
influences may be perceived very differently by patients. Influences that some
individuals easily resist, or sometimes perhaps even welcome can be felt by others
as heavily constraining.82 Totally preventing any sense of involuntariness in itself
can be difficult and needs thorough consideration of environmental as well as
individual factors. In any case, requiring prior and continuous research ethic com-
mittee approval and use of LARs may serve to work against unethical research
conduct and safeguard the individual patient’s interest when deciding whether or
not the patient should participate in a research project.
4.2 Does the presence of psychosis totally preclude a patient from making deci-
sions regarding whether or not to be a participant in a scientific investigation?
Regarding soundness of mind in consenting to research participation, the deci-
sion-making capacity of patients with severe mental disorder was recently investi-
gated by Spencer and colleagues.83 Their meta-analysis showed that decision-mak-
81. Robert M. Nelson, Tom Beauchamp, Victoria A. Miller, William Reynolds, Richard F. Ittenbach, 
and Mary Frances Luce, 'The concept of voluntary consent' (2011) 11 (8) The American Journal of 
Bioethics: AJOB 6. DOI: https://doi.org/10.1080/15265161.2011.583318.
82. Nelson et al. (n 80).
83. Benjamin Walter Jack Spencer, Gregory Shields, Tania Gergel, Matthew Hotopf and Gareth S. 
Owen, ‘Diversity or disarray? A systematic review of decision-making capacity for treatment and rese-
arch in schizophrenia and other non-affective psychoses’ (2017) 47 (11) Psychological Medicine 1906. 
DOI: https://doi.org/10.1017/s0033291717000502.
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ing capacity for treatment was present in half of their patients.84 In a subsequent
cross-sectional study of psychiatric patients with psychoses, the same research
team found that half of the participants had decision-making capacity for research
while only a third had decision-making capacity for treatment.85 The authors con-
clude that people with severe mental disorder commonly retain decision-making
capacity for non-therapeutic research. The authors emphasize that we, therefore,
should abstain from making assumptions about an individual’s decision-making
capacity for research based on the decision-making capacity for treatment, the
degree of illness, etc. as ‘To do so risks the continued exclusion of a patient group
that we know has high rates of [decision-making capacity for research] and for
whom research is urgently needed to improve care’.86 In patient groups deemed
incapable of consenting to research participation, use of independent LARs would
serve to ensure patients’ interest in decisions about research participation. Still,
the evidence regarding psychotic patients' capacity for making decisions about
research participation is scant. It is doubtful whether the legislative bodies can (or
should) be convinced to change national legislation on the basis of such scant evi-
dence. In this regard, it must be remembered that according to the research ethical
standard this is not only about ‘consenting’. A valid consent simultaneously must
be free and informed. If a patient is psychotic and is subject to coercive treatment,
it may be quite difficult to know when he or she is reasonably informed and as it
was problematized above, ensuring that a consent is truly free in a coercive setting
may make it even more difficult. At the same time, it is unclear how and by who
those capable of making ‘sound’ decisions about research participation can be reli-
ably identified among those only half of patients having this capability.
4.3 Need for reconsideration of Danish legislation regarding research in 
patients subject to coercion 
It is remarkable that in their recommendations for human rights in psychiatry, the
Danish Institute for Human Rights does not address research issues in psychiatry
settings.87 The Danish Ethical Council (DEC), however, previously emphasized
84. Spencer et al. (n 84).
85. Benjamin Walter Jack Spencer, Tania Gergel, Matthew Hotopf and Gareth S. Owen, ‘Unwell in hos-
pital but not incapable: cross-sectional study on the dissociation of decision-making capacity for treat-
ment and research in in-patients with schizophrenia and related psychoses’ (2018) The British Journal 
of Psychiatry: the Journal of Mental Science 1-6. DOI: https://doi.org/10.1192/bjp.2018.85.
86. Spencer et al. (n 85). Finally, the authors conclude that “We should not view in-patient psychiatric 
settings as a research no-go area and, with suitable safeguards, our results suggest we should recruit in 
these settings. Just because someone is in hospital with schizophrenia or related psychoses does not 
mean they are incapable. If we talk to them about research projects, they may want to – and be able to 
– participate.’
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that the acquisition of new knowledge to improve quality of healthcare in psychia-
try is highly dependent on research.88 Such research must address, e.g., whether
treatment modalities actually work or could be improved. Thus, the Council states
that it is of the greatest importance for ensuring a continuous improvement of
mental healthcare that opportunities for investigating interventions are satisfac-
tory, including both medication based interventions as well as other modes of
intervention. In this regard, the Council advocates that ‘mental health care users
should be heard about their preferences regarding research projects and research
designs’.89 It is noteworthy that the Danish Ethical Council upholds a ‘principle of
equality’ indicating the important point of view that every patient has a funda-
mental right to participate in promoting health care through research (compare
ECR Article 5, subsection 1). Correspondingly, the question remains to be
addressed as to why for example physically restrained patients should not be
‘heard about their preferences regarding research projects’ and to what extent the
possibility of ‘undue influence’ can entirely cancel out the principle of equality.
Munthe and colleagues, among others, have argued that research aiming at
improvements of treatment, etc. is a societal priority.90 While usual informed con-
sent requirements still apply, the total benefit of studies involving mentally dis-
ordered offenders, therefore, must be weighed against the risks for research sub-
jects. The authors furthermore argue that very small risks to research subjects may
be considered to be acceptable if special measures are taken to protect integrity, if
there is a general benefit of better treatment etc., and if patients retain the right to
veto participation in research. Taken together with the codes of practice and regu-
lation in the countries described above, the Danish prohibition on health research
involving patients subjected to coercion seems to merit a re-evaluation. This re-
evaluation should consider the possible harm of patient participation in this kind
of research weighed against benefits, while considering the intentions lying
behind the Nuremberg code and other human rights principles.
When turning to the Declaration of Helsinki,91 it should be recalled that the
declaration does not preclude the possibility of conducting research involving psy-
chiatric patients when obtaining valid consent from the patient concerned is
87. DIHR. [Menneskerettigheder og Tvang i Psykiatrien – Anbefalinger]. Copenhagen: The Danish 
Institute for Human Rights; 2013.
88. The Danish Ethical Council, DEC. [Psykiatriske patienters vilkår – en redegørelse]. Copenhagen: 
[Etisk Raad]; 1997.
89. DEC (n 89).
90. Christian Munthe, Susanna Radovic, and Henrik Anckarsater, 'Ethical issues in forensic psychiatric 
research on mentally disordered offenders' (2010) 24 (1) Bioethics 35. DOI: https://doi.org/10.1111/
j.1467-8519.2009.01773.x.
91. Helsinki Declaration (n 13), Para 30.
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deemed problematic (see above). Rather, the declaration upholds the principle
that research can be done if the ‘condition that prevents giving informed consent
is a necessary characteristic of the research group’ and valid informed consent can
be obtained from a LAR. The Belmont Report principles, similarly, do not pre-
clude research in coerced patients,92 but simply emphasize that the less burdened
should be called upon first to accept any risks of research, except where the
research is directly related to the specific conditions of the class involved. Accord-
ing to the Oviedo convention, when patients for one reason or another lack capac-
ity for consent, an intervention can be carried out with the authorisation of his or
her LAR.93 In the same way, our review of legislation in UK as well as Norway and
Sweden reveals that in these countries research can be conducted when coming up
to ethical review board (and, if necessary, legal representative requirements), as
well as conditions regulating which risks are acceptable in research on persons not
able to consent.
5 Conclusion
The simultaneous use of coercive measure may make obtaining valid consent dif-
ficult. However, according to European Council Recommendations there is no
ban on research involving psychiatric patients subject to coercive measures.94
Rather, it is declared that such patients have ‘a right to be treated under the same
ethical and scientific conditions as any other sick person’ and that every country
must decide whether research should be permitted (see above). When looking at
the UN Convention on the Rights of Persons with Disabilities (CRPD), it empha-
sizes that parties must recognize that all persons are equal before and under the
law and shall prohibit all discrimination on the basis of disability and that having a
disability (in this context mental disorder) is not a reason to take away persons’
right to make their own decisions (Articles 5, 12, and 14). Correspondingly, the
Danish Ethical Council has upheld the point of view that psychiatric patients have
a fundamental right to equally participate in promoting health care through
research.95 Furthermore, existing research suggests that even when psychotic in-
patients are severely unwell, they commonly retain decision-making capacity for
research participation.96
92. Belmont Report (n 18).
93. Oviedo Convention (n 4).
94. ECR (n 67).
95. DEC (n 89).
96. Spencer et al. (n 86).
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When it comes to research in patients subject to coercion, consideration must
be paid to what kind of risk patients are exposed to (either physical or integrity),
whether patients have capacity to give informed consent, whether a representative
can consent on their behalf, whether it is possible to conduct the investigation
without enrolling patients in a vulnerable position, and whether the vulnerable
group itself would benefit from the research in question. In any case, an absolute
requirement is that the patient does not object to research participation and
retains a right to withdraw from participation at any time. While acknowledging
the patient’s right to veto, both ethical guidelines, ‘soft law instruments’ and
national law in the other studied countries seem to agree on requiring ethics com-
mittee review (and in some cases consent from a legal representative) as an alter-
native, rather than simply prohibiting research.97 There are many interventions
used in psychiatric patients subject to coercion that could be improved through
research, including those that seek to reduce the use of restrictive practices such as
restraint and seclusion. Instead of issuing a total ban on research, practice in other
countries demonstrates that review of potential studies by an ethics committee,
and requiring consent from a legal representative when patients are deemed inca-
pable of consenting, but with the patient always having a final power of veto, facil-
itates research with patients subject to coercion. Patient rights can be further
strengthened by requiring continuous board review of ongoing research projects.
The restrictions on research in this area under current Danish law may be an
unfortunate barrier to service quality improvement.
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